Skip to main content
. 2021 Jun 22;12(13):1296–1308. doi: 10.18632/oncotarget.27988

Figure 2. The frequency of truncating, missense, and other (inframe and splice-site) mutations in KMT2D in different types of cancer.

Figure 2

The mutation frequencies for the cancer types listed, except medulloblastoma (Broad database), leukemia (St Jude database), and Non-Hodgkin lymphoma (Duke database), were obtained from data in TCGA PanCancer Atlas. All data were from the cBioportal database.